Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:401-407
Published online before print January 22, 2007, doi: 10.1161/01.HYP.0000256279.49882.d8
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/3/401    most recent
01.HYP.0000256279.49882.d8v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deschepper, C. F.
Right arrow Articles by Llamas, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deschepper, C. F.
Right arrow Articles by Llamas, B.
Related Collections
Right arrow Structure
Right arrow Contractile function
Right arrow Biochemistry and metabolism
Right arrow Other myocardial biology
Right arrow Animal models of human disease
Right arrow Physiological and pathological control of gene expression

(Hypertension. 2007;49:401.)
© 2007 American Heart Association, Inc.


Brief Reviews

Hypertensive Cardiac Remodeling in Males and Females

From the Bench to the Bedside

Christian F. Deschepper; Bastien Llamas

From the Experimental Cardiovascular Biology Research Unit, Institut de Recherches Cliniques de Montréal, Montréal, Quebec, Canada; and the Université de Montréal, Montréal, Quebec, Canada.

Correspondence to Christian F. Deschepper, Institut de Recherches Cliniques de Montréal, 110 Pine Ave West, Montréal, Quebec, Canada H2W 1R7. E-mail christian.deschepper@ircm.qc.ca


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Cardiovascular diseases affect women and men differently: there are sex-dependent differences in the age at which they become manifest, in the pathophysiologic consequences of various insults, in the relative importance of risk factors, and in the responses to several treatments (as reviewed recently).1,2 Although many of these differences may relate to modifications of the lipid profile, as well as differences in the functions of endothelial and/or vascular smooth muscle cells, it is becoming clear that direct actions within the heart itself must also be considered. The current review will, therefore, focus on sex-specific differences in the remodeling responses of cardiac ventricles to various challenges.


*    Sex-Dependent Differences in Cardiac Remodeling
 
At baseline, male and female hearts display several differences: (1) coronary artery size is smaller in women3; (2) there are differences in the electrophysiological properties of the hearts, as females have faster resting heart rates and longer rate-corrected QT intervals4,5; (3) male and female hearts differ in terms of the pattern of expression of certain genes6; and (4) there are differences in the contractile properties of male and female hearts.7,8 More importantly, there are significant differences in the way male and female hearts respond to various challenges. In rodents, aortic banding-induced pressure overload increases left ventricular mass to the same extent in males and females, but function is better preserved in females, and males show an early transition to heart failure.9,10 In rats, volume overload induces eccentric dilated hypertrophy in male Sprague–Dawley rats but not in females.11 Differences in the remodeling responses can . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
HypertensionHome page
N. Reichek, R. B. Devereux, R. A. Rocha, R. Hilkert, D. Hall, D. Purkayastha, and B. Pitt
Magnetic Resonance Imaging Left Ventricular Mass Reduction With Fixed-Dose Angiotensin-Converting Enzyme Inhibitor-Based Regimens in Patients With High-Risk Hypertension
Hypertension, October 1, 2009; 54(4): 731 - 737.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Gao, C.-L. Long, R.-H. Wang, and H. Wang
KATP activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function
Cardiovasc Res, August 1, 2009; 83(3): 444 - 456.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
D. R. Fermin, A. Barac, S. Lee, S. P. Polster, S. Hannenhalli, T. L. Bergemann, S. Grindle, D. B. Dyke, F. Pagani, L. W. Miller, et al.
Sex and Age Dimorphism of Myocardial Gene Expression in Nonischemic Human Heart Failure
Circ Cardiovasc Genet, December 1, 2008; 1(2): 117 - 125.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Karatas, B. Hegner, L. J. de Windt, F. C. Luft, C. Schubert, V. Gross, Y. J. Akashi, D. Gurgen, U. Kintscher, A. C. da Costa Goncalves, et al.
Deoxycorticosterone Acetate-Salt Mice Exhibit Blood Pressure-Independent Sexual Dimorphism
Hypertension, April 1, 2008; 51(4): 1177 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
B. Llamas, S. Belanger, S. Picard, and C. F. Deschepper
Cardiac mass and cardiomyocyte size are governed by different genetic loci on either autosomes or chromosome Y in recombinant inbred mice
Physiol Genomics, October 19, 2007; 31(2): 176 - 182.
[Abstract] [Full Text] [PDF]